![Sergio Cifuentes: Key potential insights in immunotherapy of maintenance in women with high T-cell Clonality](https://oncodaily.com/pub/uploads/2024/05/Sergio-Cifuentes-1.jpg)
May 25, 2024, 08:53
Sergio Cifuentes: Key potential insights in immunotherapy of maintenance in women with high T-cell Clonality
Sergio Cifuentes, Student Fellow at National Autonomous University of Mexico, shared on X:
“Maintenance Pembrolizumab for HER2- mBC.
– 43 women (32 TNBC): CR, PR, or SD after 3 cycles of chemotherapy,
– 4m DCR: 58.1%,
– mPFS: 4.8 m,
– T-cell Clonality: PFS 10.4 vs. 3.6.
Key potential insights in immunotherapy of maintenance in women with high T-cell Clonality.”
Proceed to the article.
Source: Sergio Cifuentes/X
Jul 1, 2024, 19:16